Loading…
Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats
Leptin gains access to the central nervous system where it influences activity of neuronal networks involved in ingestive behavior, neuroendocrine activity, and metabolism. In particular, the brain melanocortin (MC) system is important in leptin signaling and maintenance of energy balance. Although...
Saved in:
Published in: | Endocrinology (Philadelphia) 2005-12, Vol.146 (12), p.5247-5256 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23 |
---|---|
cites | cdi_FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23 |
container_end_page | 5256 |
container_issue | 12 |
container_start_page | 5247 |
container_title | Endocrinology (Philadelphia) |
container_volume | 146 |
creator | van Dijk, Gertjan de Vries, Koert Nyakas, Csaba Buwalda, Bauke Adage, Tiziana Kuipers, Folkert Kas, Martien J. H Adan, Roger A. H Wilkinson, Charles W Thiele, Todd E Scheurink, Anton J. W |
description | Leptin gains access to the central nervous system where it influences activity of neuronal networks involved in ingestive behavior, neuroendocrine activity, and metabolism. In particular, the brain melanocortin (MC) system is important in leptin signaling and maintenance of energy balance. Although leptin or MC receptor insensitivity has been proposed to be associated with obesity, the present study compared central leptin and MC receptor stimulation on some of the above-mentioned parameters and investigated whether these treatments predict proneness to diet-induced obesity (DIO) in outbred Wistar rats. Third-cerebroventricular administration of equi-anorexigenic doses of leptin and of the MC agonist melanotan-II caused comparable increases in plasma ACTH and corticosterone levels and c-Fos-labeling in approximately 70% of paraventricular hypothalamic (PVN) neuronal cell bodies containing CRH. This reinforces involvement of paraventricular CRH neurons in the short-term neuroendocrine and ingestive effects of leptin and melanocortins. In the DIO prediction study, anorexigenic efficacy of melanotan-II was not correlated with any parameter linked to DIO but was highly correlated with MC in situ binding (with labeled [Nle4,d-Phe7]α-MSH) as well as CRH immunoreactivity in the PVN of DIO rats. This suggests intricate relationships among MC signaling, the CRH system, and ingestive behavior unrelated to DIO. In the same animals, leptin’s anorexigenic efficacy was not correlated with PVN MC in situ binding or CRH immunoreactivity but correlated inversely to post-DIO plasma leptin, liver weight, and abdominal adiposity, the latter being correlated to insulin resistance. Thus, differences in leptin but not MC signaling might underlie DIO, visceral obesity, and insulin resistance. |
doi_str_mv | 10.1210/en.2005-0472 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1360237</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/en.2005-0472</oup_id><sourcerecordid>3130575325</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23</originalsourceid><addsrcrecordid>eNp1kV-LEzEUxYMobq2--SwBUV86a_5MJtMXoa6rFqoriz6HNHPTzdImNcmI_Qh-azN0sCr6FJL7yz3ncBB6TMk5ZZS8BH_OCBEVqSW7gyZ0XotKUknuogkhlFeSMXmGHqR0W651XfP76Iw2tGkYYxP04xq63kCHFz5E-O424J3Bl9Y6o80BB4tXsM_Oz_DrPuOPIQ9P-QbwB9hqH0yIZYivwRQqRLzYBO9SHqdZ-2q5nOFPETpncsJvHORq6Y-KV2tILh_w8F_n9BDds3qb4NF4TtGXt5efL95Xq6t3y4vFqjKilrliNRVW8w54a4TmLWulNMxqy6mds65t63VJJgmTTWuh7uScWTJfG2ZEI6RlfIpeHffu-_UOOgM-R71V--h2Oh5U0E79OfHuRm3CN0V5QxiXZcHzcUEMX3tIWe1cMrAtiSH0SdE5l20tBqWnf4G3oY--hFOcciKk4EwUanakTAwpRbC_rFCihoYVeDU0rIaGC_7kd_sneKy0AM9GQCejtzZqb1w6cZLJlhePU_TiyIV-_z_JapTkRxJ8F0x0HvYRUjql-afRn3xUy4A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130575325</pqid></control><display><type>article</type><title>Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats</title><source>Oxford Journals Online</source><creator>van Dijk, Gertjan ; de Vries, Koert ; Nyakas, Csaba ; Buwalda, Bauke ; Adage, Tiziana ; Kuipers, Folkert ; Kas, Martien J. H ; Adan, Roger A. H ; Wilkinson, Charles W ; Thiele, Todd E ; Scheurink, Anton J. W</creator><creatorcontrib>van Dijk, Gertjan ; de Vries, Koert ; Nyakas, Csaba ; Buwalda, Bauke ; Adage, Tiziana ; Kuipers, Folkert ; Kas, Martien J. H ; Adan, Roger A. H ; Wilkinson, Charles W ; Thiele, Todd E ; Scheurink, Anton J. W</creatorcontrib><description>Leptin gains access to the central nervous system where it influences activity of neuronal networks involved in ingestive behavior, neuroendocrine activity, and metabolism. In particular, the brain melanocortin (MC) system is important in leptin signaling and maintenance of energy balance. Although leptin or MC receptor insensitivity has been proposed to be associated with obesity, the present study compared central leptin and MC receptor stimulation on some of the above-mentioned parameters and investigated whether these treatments predict proneness to diet-induced obesity (DIO) in outbred Wistar rats. Third-cerebroventricular administration of equi-anorexigenic doses of leptin and of the MC agonist melanotan-II caused comparable increases in plasma ACTH and corticosterone levels and c-Fos-labeling in approximately 70% of paraventricular hypothalamic (PVN) neuronal cell bodies containing CRH. This reinforces involvement of paraventricular CRH neurons in the short-term neuroendocrine and ingestive effects of leptin and melanocortins. In the DIO prediction study, anorexigenic efficacy of melanotan-II was not correlated with any parameter linked to DIO but was highly correlated with MC in situ binding (with labeled [Nle4,d-Phe7]α-MSH) as well as CRH immunoreactivity in the PVN of DIO rats. This suggests intricate relationships among MC signaling, the CRH system, and ingestive behavior unrelated to DIO. In the same animals, leptin’s anorexigenic efficacy was not correlated with PVN MC in situ binding or CRH immunoreactivity but correlated inversely to post-DIO plasma leptin, liver weight, and abdominal adiposity, the latter being correlated to insulin resistance. Thus, differences in leptin but not MC signaling might underlie DIO, visceral obesity, and insulin resistance.</description><identifier>ISSN: 0013-7227</identifier><identifier>EISSN: 1945-7170</identifier><identifier>DOI: 10.1210/en.2005-0472</identifier><identifier>PMID: 16166222</identifier><identifier>CODEN: ENDOAO</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Adipose tissue ; Adrenocorticotropic hormone ; Agonists ; alpha-MSH - administration & dosage ; alpha-MSH - analogs & derivatives ; alpha-MSH - pharmacology ; Animals ; Anorexia - chemically induced ; Binding ; Biological and medical sciences ; c-Fos protein ; Central nervous system ; Correlation ; Corticosterone ; Diet ; Eating - drug effects ; Effectiveness ; Energy balance ; Fundamental and applied biological sciences. Psychology ; Humans ; Hypothalamus ; Immunoreactivity ; Injections, Intraventricular ; Insulin ; Insulin resistance ; Leptin ; Leptin - administration & dosage ; Leptin - pharmacology ; Male ; Medical sciences ; Melanocortin ; Metabolic diseases ; Neural networks ; Neuroendocrine system ; Neurons - drug effects ; Neurosecretory Systems - drug effects ; Obesity ; Obesity - etiology ; Parameters ; Paraventricular Hypothalamic Nucleus - drug effects ; Paraventricular Hypothalamic Nucleus - physiopathology ; Peptides, Cyclic - administration & dosage ; Peptides, Cyclic - pharmacology ; Predictive Value of Tests ; Rats ; Rats, Wistar ; Receptors ; Receptors, Leptin ; Receptors, Melanocortin - agonists ; Vertebrates: endocrinology</subject><ispartof>Endocrinology (Philadelphia), 2005-12, Vol.146 (12), p.5247-5256</ispartof><rights>Copyright © 2005 by The Endocrine Society 2005</rights><rights>2006 INIST-CNRS</rights><rights>Copyright © 2005 by The Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23</citedby><cites>FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17278319$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16166222$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Dijk, Gertjan</creatorcontrib><creatorcontrib>de Vries, Koert</creatorcontrib><creatorcontrib>Nyakas, Csaba</creatorcontrib><creatorcontrib>Buwalda, Bauke</creatorcontrib><creatorcontrib>Adage, Tiziana</creatorcontrib><creatorcontrib>Kuipers, Folkert</creatorcontrib><creatorcontrib>Kas, Martien J. H</creatorcontrib><creatorcontrib>Adan, Roger A. H</creatorcontrib><creatorcontrib>Wilkinson, Charles W</creatorcontrib><creatorcontrib>Thiele, Todd E</creatorcontrib><creatorcontrib>Scheurink, Anton J. W</creatorcontrib><title>Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats</title><title>Endocrinology (Philadelphia)</title><addtitle>Endocrinology</addtitle><description>Leptin gains access to the central nervous system where it influences activity of neuronal networks involved in ingestive behavior, neuroendocrine activity, and metabolism. In particular, the brain melanocortin (MC) system is important in leptin signaling and maintenance of energy balance. Although leptin or MC receptor insensitivity has been proposed to be associated with obesity, the present study compared central leptin and MC receptor stimulation on some of the above-mentioned parameters and investigated whether these treatments predict proneness to diet-induced obesity (DIO) in outbred Wistar rats. Third-cerebroventricular administration of equi-anorexigenic doses of leptin and of the MC agonist melanotan-II caused comparable increases in plasma ACTH and corticosterone levels and c-Fos-labeling in approximately 70% of paraventricular hypothalamic (PVN) neuronal cell bodies containing CRH. This reinforces involvement of paraventricular CRH neurons in the short-term neuroendocrine and ingestive effects of leptin and melanocortins. In the DIO prediction study, anorexigenic efficacy of melanotan-II was not correlated with any parameter linked to DIO but was highly correlated with MC in situ binding (with labeled [Nle4,d-Phe7]α-MSH) as well as CRH immunoreactivity in the PVN of DIO rats. This suggests intricate relationships among MC signaling, the CRH system, and ingestive behavior unrelated to DIO. In the same animals, leptin’s anorexigenic efficacy was not correlated with PVN MC in situ binding or CRH immunoreactivity but correlated inversely to post-DIO plasma leptin, liver weight, and abdominal adiposity, the latter being correlated to insulin resistance. Thus, differences in leptin but not MC signaling might underlie DIO, visceral obesity, and insulin resistance.</description><subject>Adipose tissue</subject><subject>Adrenocorticotropic hormone</subject><subject>Agonists</subject><subject>alpha-MSH - administration & dosage</subject><subject>alpha-MSH - analogs & derivatives</subject><subject>alpha-MSH - pharmacology</subject><subject>Animals</subject><subject>Anorexia - chemically induced</subject><subject>Binding</subject><subject>Biological and medical sciences</subject><subject>c-Fos protein</subject><subject>Central nervous system</subject><subject>Correlation</subject><subject>Corticosterone</subject><subject>Diet</subject><subject>Eating - drug effects</subject><subject>Effectiveness</subject><subject>Energy balance</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Hypothalamus</subject><subject>Immunoreactivity</subject><subject>Injections, Intraventricular</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Leptin</subject><subject>Leptin - administration & dosage</subject><subject>Leptin - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Melanocortin</subject><subject>Metabolic diseases</subject><subject>Neural networks</subject><subject>Neuroendocrine system</subject><subject>Neurons - drug effects</subject><subject>Neurosecretory Systems - drug effects</subject><subject>Obesity</subject><subject>Obesity - etiology</subject><subject>Parameters</subject><subject>Paraventricular Hypothalamic Nucleus - drug effects</subject><subject>Paraventricular Hypothalamic Nucleus - physiopathology</subject><subject>Peptides, Cyclic - administration & dosage</subject><subject>Peptides, Cyclic - pharmacology</subject><subject>Predictive Value of Tests</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors</subject><subject>Receptors, Leptin</subject><subject>Receptors, Melanocortin - agonists</subject><subject>Vertebrates: endocrinology</subject><issn>0013-7227</issn><issn>1945-7170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp1kV-LEzEUxYMobq2--SwBUV86a_5MJtMXoa6rFqoriz6HNHPTzdImNcmI_Qh-azN0sCr6FJL7yz3ncBB6TMk5ZZS8BH_OCBEVqSW7gyZ0XotKUknuogkhlFeSMXmGHqR0W651XfP76Iw2tGkYYxP04xq63kCHFz5E-O424J3Bl9Y6o80BB4tXsM_Oz_DrPuOPIQ9P-QbwB9hqH0yIZYivwRQqRLzYBO9SHqdZ-2q5nOFPETpncsJvHORq6Y-KV2tILh_w8F_n9BDds3qb4NF4TtGXt5efL95Xq6t3y4vFqjKilrliNRVW8w54a4TmLWulNMxqy6mds65t63VJJgmTTWuh7uScWTJfG2ZEI6RlfIpeHffu-_UOOgM-R71V--h2Oh5U0E79OfHuRm3CN0V5QxiXZcHzcUEMX3tIWe1cMrAtiSH0SdE5l20tBqWnf4G3oY--hFOcciKk4EwUanakTAwpRbC_rFCihoYVeDU0rIaGC_7kd_sneKy0AM9GQCejtzZqb1w6cZLJlhePU_TiyIV-_z_JapTkRxJ8F0x0HvYRUjql-afRn3xUy4A</recordid><startdate>20051201</startdate><enddate>20051201</enddate><creator>van Dijk, Gertjan</creator><creator>de Vries, Koert</creator><creator>Nyakas, Csaba</creator><creator>Buwalda, Bauke</creator><creator>Adage, Tiziana</creator><creator>Kuipers, Folkert</creator><creator>Kas, Martien J. H</creator><creator>Adan, Roger A. H</creator><creator>Wilkinson, Charles W</creator><creator>Thiele, Todd E</creator><creator>Scheurink, Anton J. W</creator><general>Endocrine Society</general><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20051201</creationdate><title>Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats</title><author>van Dijk, Gertjan ; de Vries, Koert ; Nyakas, Csaba ; Buwalda, Bauke ; Adage, Tiziana ; Kuipers, Folkert ; Kas, Martien J. H ; Adan, Roger A. H ; Wilkinson, Charles W ; Thiele, Todd E ; Scheurink, Anton J. W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adipose tissue</topic><topic>Adrenocorticotropic hormone</topic><topic>Agonists</topic><topic>alpha-MSH - administration & dosage</topic><topic>alpha-MSH - analogs & derivatives</topic><topic>alpha-MSH - pharmacology</topic><topic>Animals</topic><topic>Anorexia - chemically induced</topic><topic>Binding</topic><topic>Biological and medical sciences</topic><topic>c-Fos protein</topic><topic>Central nervous system</topic><topic>Correlation</topic><topic>Corticosterone</topic><topic>Diet</topic><topic>Eating - drug effects</topic><topic>Effectiveness</topic><topic>Energy balance</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Hypothalamus</topic><topic>Immunoreactivity</topic><topic>Injections, Intraventricular</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Leptin</topic><topic>Leptin - administration & dosage</topic><topic>Leptin - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Melanocortin</topic><topic>Metabolic diseases</topic><topic>Neural networks</topic><topic>Neuroendocrine system</topic><topic>Neurons - drug effects</topic><topic>Neurosecretory Systems - drug effects</topic><topic>Obesity</topic><topic>Obesity - etiology</topic><topic>Parameters</topic><topic>Paraventricular Hypothalamic Nucleus - drug effects</topic><topic>Paraventricular Hypothalamic Nucleus - physiopathology</topic><topic>Peptides, Cyclic - administration & dosage</topic><topic>Peptides, Cyclic - pharmacology</topic><topic>Predictive Value of Tests</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors</topic><topic>Receptors, Leptin</topic><topic>Receptors, Melanocortin - agonists</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Dijk, Gertjan</creatorcontrib><creatorcontrib>de Vries, Koert</creatorcontrib><creatorcontrib>Nyakas, Csaba</creatorcontrib><creatorcontrib>Buwalda, Bauke</creatorcontrib><creatorcontrib>Adage, Tiziana</creatorcontrib><creatorcontrib>Kuipers, Folkert</creatorcontrib><creatorcontrib>Kas, Martien J. H</creatorcontrib><creatorcontrib>Adan, Roger A. H</creatorcontrib><creatorcontrib>Wilkinson, Charles W</creatorcontrib><creatorcontrib>Thiele, Todd E</creatorcontrib><creatorcontrib>Scheurink, Anton J. W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Endocrinology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Dijk, Gertjan</au><au>de Vries, Koert</au><au>Nyakas, Csaba</au><au>Buwalda, Bauke</au><au>Adage, Tiziana</au><au>Kuipers, Folkert</au><au>Kas, Martien J. H</au><au>Adan, Roger A. H</au><au>Wilkinson, Charles W</au><au>Thiele, Todd E</au><au>Scheurink, Anton J. W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats</atitle><jtitle>Endocrinology (Philadelphia)</jtitle><addtitle>Endocrinology</addtitle><date>2005-12-01</date><risdate>2005</risdate><volume>146</volume><issue>12</issue><spage>5247</spage><epage>5256</epage><pages>5247-5256</pages><issn>0013-7227</issn><eissn>1945-7170</eissn><coden>ENDOAO</coden><abstract>Leptin gains access to the central nervous system where it influences activity of neuronal networks involved in ingestive behavior, neuroendocrine activity, and metabolism. In particular, the brain melanocortin (MC) system is important in leptin signaling and maintenance of energy balance. Although leptin or MC receptor insensitivity has been proposed to be associated with obesity, the present study compared central leptin and MC receptor stimulation on some of the above-mentioned parameters and investigated whether these treatments predict proneness to diet-induced obesity (DIO) in outbred Wistar rats. Third-cerebroventricular administration of equi-anorexigenic doses of leptin and of the MC agonist melanotan-II caused comparable increases in plasma ACTH and corticosterone levels and c-Fos-labeling in approximately 70% of paraventricular hypothalamic (PVN) neuronal cell bodies containing CRH. This reinforces involvement of paraventricular CRH neurons in the short-term neuroendocrine and ingestive effects of leptin and melanocortins. In the DIO prediction study, anorexigenic efficacy of melanotan-II was not correlated with any parameter linked to DIO but was highly correlated with MC in situ binding (with labeled [Nle4,d-Phe7]α-MSH) as well as CRH immunoreactivity in the PVN of DIO rats. This suggests intricate relationships among MC signaling, the CRH system, and ingestive behavior unrelated to DIO. In the same animals, leptin’s anorexigenic efficacy was not correlated with PVN MC in situ binding or CRH immunoreactivity but correlated inversely to post-DIO plasma leptin, liver weight, and abdominal adiposity, the latter being correlated to insulin resistance. Thus, differences in leptin but not MC signaling might underlie DIO, visceral obesity, and insulin resistance.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>16166222</pmid><doi>10.1210/en.2005-0472</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0013-7227 |
ispartof | Endocrinology (Philadelphia), 2005-12, Vol.146 (12), p.5247-5256 |
issn | 0013-7227 1945-7170 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1360237 |
source | Oxford Journals Online |
subjects | Adipose tissue Adrenocorticotropic hormone Agonists alpha-MSH - administration & dosage alpha-MSH - analogs & derivatives alpha-MSH - pharmacology Animals Anorexia - chemically induced Binding Biological and medical sciences c-Fos protein Central nervous system Correlation Corticosterone Diet Eating - drug effects Effectiveness Energy balance Fundamental and applied biological sciences. Psychology Humans Hypothalamus Immunoreactivity Injections, Intraventricular Insulin Insulin resistance Leptin Leptin - administration & dosage Leptin - pharmacology Male Medical sciences Melanocortin Metabolic diseases Neural networks Neuroendocrine system Neurons - drug effects Neurosecretory Systems - drug effects Obesity Obesity - etiology Parameters Paraventricular Hypothalamic Nucleus - drug effects Paraventricular Hypothalamic Nucleus - physiopathology Peptides, Cyclic - administration & dosage Peptides, Cyclic - pharmacology Predictive Value of Tests Rats Rats, Wistar Receptors Receptors, Leptin Receptors, Melanocortin - agonists Vertebrates: endocrinology |
title | Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T21%3A48%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20Anorexigenic%20Efficacy%20of%20Leptin,%20But%20Not%20of%20the%20Melanocortin%20Receptor%20Agonist%20Melanotan-II,%20Predicts%20Diet-Induced%20Obesity%20in%20Rats&rft.jtitle=Endocrinology%20(Philadelphia)&rft.au=van%20Dijk,%20Gertjan&rft.date=2005-12-01&rft.volume=146&rft.issue=12&rft.spage=5247&rft.epage=5256&rft.pages=5247-5256&rft.issn=0013-7227&rft.eissn=1945-7170&rft.coden=ENDOAO&rft_id=info:doi/10.1210/en.2005-0472&rft_dat=%3Cproquest_pubme%3E3130575325%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c547t-2415fa3de38c5a382877c2faf31f92d884b622702768fe4d792f09bc2c5657f23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3130575325&rft_id=info:pmid/16166222&rft_oup_id=10.1210/en.2005-0472&rfr_iscdi=true |